Facet’s strategic and tactical regulatory affairs, statistics, regulatory writing, and commercialization experts lead small organizations to faster and more efficient product development, US registration, and commercial launch.
Facet has used statistical modeling and simulations to greatly improve clinical trial success in Phase 2 and Phase 3.
Facet’s regulatory experts set the strategy and lead the tactical plans to prepare and submit 3-5 US marketing applications each year.
Preparations for commercial launch and reimbursement are a necessary part of product development. Even if you are not planning to take your product to US approval, a robust commercialization plan adds value to your asset and helps you communicate with potential acquirers/partners.